Careers  |  Sign In  |  Register  |   Twitter

Latest in Ob/Gyn

CO2 micro-ablative laser therapy shows potential to emerge as a new treatment option for certain vaginal and vulvar disorders in the near future.
Approximately 40% of pregnancies worldwide are unintended.
The Proteomic Assessment of Preterm Birth (PAPR) study conducted by Sera Prognostics, Inc. has yielded information that led to the development of a test which can help physicians determine which pregnant patients are at greater risk of having a pre-term birth. The PreTRM test analyzes proteins covering...